drugset / Trial / NCT06310616

A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

NCT06310616

Phase 1 Completed 26 enrolled ViiV Healthcare
Non-randomizedSequentialOpen-labelTreatment

Summary

This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.

Timeline

Start
2024-03-06
Primary completion
2024-08-15
Completion
2024-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Loestrin Unknown Oral
Subject VH4524184 Unknown